{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:29:27Z","timestamp":1783913367518,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T00:00:00Z","timestamp":1319500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The development of hVISA has been associated with vancomycin clinical failures and is commonly misidentified in clinical microbiology laboratories. Therefore, the objectives of this present study was to improve the reliability of methodologies and criteria for identifying hVISA, evaluate the prevalence of hVISA among clinical bloodstream isolates of <jats:italic>S. aureus<\/jats:italic> and determine if there exists a relationship between accessory gene regulator (<jats:italic>agr)<\/jats:italic> dysfunction and the hVISA phenotype.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The presence of hVISA in 220 clinical <jats:italic>S. aureus<\/jats:italic> isolates (121 MSSA, 99 MRSA) from bloodstream infections was examined by CLSI broth microdilution, Macro &amp; Standard Etest. Isolates which were classified as hVISA by Macro Etest, were additionally evaluated using a modified PAP-AUC method using a modified starting inoculum of 10<jats:sup>10<\/jats:sup> CFU\/mL, and growth on brain heart infusion agar with 4 mg\/L vancomycin (BHIV4) at 10<jats:sup>8<\/jats:sup> and 10<jats:sup>10<\/jats:sup> CFU\/mL, and <jats:italic>agr<\/jats:italic> function was assessed by delta-hemolysin production.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Broth microdilution MIC<jats:sub>50\/90<\/jats:sub> of <jats:italic>S.aureus<\/jats:italic> and hVISA was 1.0\/2.0 and 1.5\/2.0 mg\/L (<jats:italic>p<\/jats:italic>= 0.02), respectively. Macro Etest identified 12 (5.5%) hVISA isolates; higher among MRSA (9.1%) versus MSSA (2.5%) (<jats:italic>p<\/jats:italic> = 0.03). The mean modified PAP-AUC ratios (&gt; 0.8) of 7 MRSA strains and 3 MSSA strains were significantly different (<jats:italic>p<\/jats:italic> = 0.001). 58% of hVISA strains were found to be <jats:italic>agr<\/jats:italic> dysfunctional when 21% of MRSA strains were <jats:italic>agr<\/jats:italic> dysfunctional. hVISA was detected among <jats:italic>S. aureus<\/jats:italic> bloodstream isolates, which were classified as susceptible among clinical microbiology laboratories.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Evaluating the correlation between Etest MICs and modified PAP-AUC ratio values will add further improvement of discriminating hVISA, and <jats:italic>agr<\/jats:italic> dysfunction may be predictive of strains which display a greater predilection to display the hVISA phenotype.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-11-287","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T13:51:02Z","timestamp":1321451462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus"],"prefix":"10.1186","volume":"11","author":[{"given":"Yoriko","family":"Harigaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Lesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanthida","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,25]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3201\/eid1005.030556","volume":"10","author":"RA Howe","year":"2004","unstructured":"Howe RA, Monk A, Wootton M, Walsh TR, Enright MC: Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis. 2004, 10: 855-857.","journal-title":"Emerg Infect Dis"},{"key":"1626_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.micro.56.012302.160806","volume":"56","author":"TR Walsh","year":"2002","unstructured":"Walsh TR, Howe RA: The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol. 2002, 56: 657-675. 10.1146\/annurev.micro.56.012302.160806.","journal-title":"Annu Rev Microbiol"},{"key":"1626_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/596629","volume":"199","author":"Y Maor","year":"2009","unstructured":"Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G: Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis. 2009, 199: 619-624. 10.1086\/596629.","journal-title":"J Infect Dis"},{"key":"1626_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","volume":"30","author":"PC Appelbaum","year":"2007","unstructured":"Appelbaum PC: Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2007, 30: 398-408. 10.1016\/j.ijantimicag.2007.07.011.","journal-title":"Int J Antimicrob Agents"},{"key":"1626_CR5","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","volume":"47","author":"C Liu","year":"2003","unstructured":"Liu C, Chambers HF: Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003, 47: 3040-3045. 10.1128\/AAC.47.10.3040-3045.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"1626_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997, 350: 1670-1673. 10.1016\/S0140-6736(97)07324-8.","journal-title":"Lancet"},{"key":"1626_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jac\/47.4.399","volume":"47","author":"M Wootton","year":"2001","unstructured":"Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP: A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother. 2001, 47: 399-403. 10.1093\/jac\/47.4.399.","journal-title":"J Antimicrob Chemother"},{"key":"1626_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-0711-6-9","volume":"6","author":"A Voss","year":"2007","unstructured":"Voss A, Mouton JW, van Elzakker EP, Hendrix RG, Goessens W, Kluytmans JA, Krabbe PF, de Neeling HJ, Sloos JH, Oztoprak N, et al: A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA). Ann Clin Microbiol Antimicrob. 2007, 6: 9-10.1186\/1476-0711-6-9.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1626_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1128\/JCM.01508-06","volume":"45","author":"M Wootton","year":"2007","unstructured":"Wootton M, MacGowan AP, Walsh TR, Howe RA: A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol. 2007, 45: 329-332. 10.1128\/JCM.01508-06.","journal-title":"J Clin Microbiol"},{"key":"1626_CR10","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1128\/JCM.00265-08","volume":"46","author":"A Yusof","year":"2008","unstructured":"Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR: Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol. 2008, 46: 3042-3047. 10.1128\/JCM.00265-08.","journal-title":"J Clin Microbiol"},{"key":"1626_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2180-8-39","volume":"8","author":"BP Howden","year":"2008","unstructured":"Howden BP, Smith DJ, Mansell A, Johnson PD, Ward PB, Stinear TP, Davies JK: Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol. 2008, 8: 39-10.1186\/1471-2180-8-39.","journal-title":"BMC Microbiol"},{"key":"1626_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/jac\/dkh086","volume":"53","author":"M Wootton","year":"2004","unstructured":"Wootton M, Avison MB, Bennett PM, Howe RA, MacGowan AP, Walsh TR: Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA. J Antimicrob Chemother. 2004, 53: 406-407. 10.1093\/jac\/dkh086.","journal-title":"J Antimicrob Chemother"},{"key":"1626_CR13","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","volume":"46","author":"G Sakoulas","year":"2002","unstructured":"Sakoulas G, Eliopoulos GM, Moellering RC, Wennersten C, Venkataraman L, Novick RP, Gold HS: Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2002, 46: 1492-1502. 10.1128\/AAC.46.5.1492-1502.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"1626_CR14","volume-title":"Book Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15","author":"CLSI","year":"2005","unstructured":"CLSI, Institute CaLS: Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15. Book Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15. 2005, City: CLSI, (Editor ed.^eds.)"},{"key":"1626_CR15","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","volume":"39","author":"TR Walsh","year":"2001","unstructured":"Walsh TR, Bolmstrom A, Qwarnstrom A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D: Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. Journal of clinical microbiology. 2001, 39: 2439-2444. 10.1128\/JCM.39.7.2439-2444.2001.","journal-title":"Journal of clinical microbiology"},{"key":"1626_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1128\/JCM.01262-06","volume":"45","author":"Y Maor","year":"2007","unstructured":"Maor Y, Rahav G, Belausov N, Ben-David D, Smollan G, Keller N: Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center. J Clin Microbiol. 2007, 45: 1511-1514. 10.1128\/JCM.01262-06.","journal-title":"J Clin Microbiol"},{"key":"1626_CR17","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/JCM.01388-06","volume":"44","author":"G Wang","year":"2006","unstructured":"Wang G, Hindler JF, Ward KW, Bruckner DA: Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period. J Clin Microbiol. 2006, 44: 3883-3886. 10.1128\/JCM.01388-06.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-287\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:07:31Z","timestamp":1630516051000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-287","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,25]]},"assertion":[{"value":"17 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"287"}}